Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastrointest Endosc. Apr 16, 2025; 17(4): 104097
Published online Apr 16, 2025. doi: 10.4253/wjge.v17.i4.104097
Table 1 Baseline data and proportions of pathological diagnoses by biopsy site, n (%)

Gastroscopes
NAG, %
AG/IM, %
GPLs, %
GC, %
Other tumors, %
Total45805 (100)62.4528.985.642.750.18
Age groups (median age, 55 years; range: 18-95 years)
    18-49 years15005 (32.76)25.136.380.940.280.03
    50-69 years25037 (54.66)31.6918.023.531.320.10
    ≥ 70 years5763 (12.58)5.644.581.171.150.05
Sex
    Male24455 (53.39)31.5616.163.701.900.06
    Female21350 (46.61)30.8912.821.930.840.12
Table 2 Distribution of diseases in different regions of the stomach, n (%)

Total
NAG, %
AG/IM, %
GPLs, %
GC, %
Other tumors, %
Total53584 (100)64.2227.945.092.710.17
Cardia2135 (3.98)2.470.990.250.270.00
Gastric body13599 (25.38)20.363.460.600.960.10
Antrum27201 (50.76)31.7115.472.750.840.04
Angularis8583 (16.02)6.237.781.450.570.02
Fundus1730 (3.23)3.090.060.020.050.01
Pylorus336 (0.63)0.380.200.030.020.00
Table 3 Relationship between endoscopist biopsy rate and positive/negative lesion detection, n (%)
Endoscopist
EBR
Gastroscopes
GPCs
GPLs
Negative biopsies
EBR group
OR for GPCs, 95%CI
OR for GPLs, 95%CI
OR for negative biopsies, 95%CI
113.94%146619 (21.84)0 (0)63 (72.41)Low EBR (13.94%-23.44%)1.00, -1.00, -1.00, -
217.06%166829 (23.58)3 (2.44)86 (69.92)
318.95%108865527 (29.28)136 (7.56)1052 (58.44)
421.23%5268118 (25.93)22 (4.84)303 (66.59)
521.53%32126347 (24.47)52 (3.67)968 (68.27)
621.96%19484238 (24.64)52 (5.38)645 (66.77)
722.15%16212280 (23.08)66 (5.44)820 (67.6)
822.30%7349139 (25.23)37 (6.72)357 (64.79)
923.16%35092277 (21.9)64 (5.06)883 (69.8)
1023.44%39896487 (28.15)113 (6.53)1083 (62.6)
1123.48%10006267 (30.34)37 (4.2)551 (62.61)Moderate EBR (23.45%-25.98%)1.16, 1.09-1.240.95, 0.86-1.050.89, 0.84-0.94
1223.67%6820189 (28.29)31 (4.64)429 (64.22)
1323.68%16172311 (23.52)46 (3.48)924 (69.89)
1423.72%3992103 (29.26)15 (4.26)222 (63.07)
1524.18%18608350 (29.79)52 (4.43)737 (62.72)
1624.42%27558415 (27.36)103 (6.79)957 (63.09)
1724.80%9816279 (31.89)51 (5.83)518 (59.2)
1824.96%1322051638 (27.42)358 (5.99)3717 (62.23)
1925.98%27800423 (29.27)131 (9.07)846 (58.55)
2026.35%4666171 (36.85)24 (5.17)255 (54.96)High EBR (25.99%-31.39%)1.28, 1.19-1.380.94, 0.84-1.050.82, 0.76-0.88
2127.49%5890185 (29.55)21 (3.35)398 (63.58)
2228.15%22349409 (30.16)61 (4.5)855 (63.05)
2328.37%17985383 (27.81)71 (5.16)887 (64.42)
2428.90%12956412 (27.93)86 (5.83)947 (64.2)
2529.65%18638426 (30.45)82 (5.86)864 (61.76)
2630.16%18413292 (26.67)50 (4.57)732 (66.85)
2731.08%19148397 (33.5)64 (5.4)698 (58.9)
2831.39%25385379 (29.61)57 (4.45)829 (64.77)
2932.55%18142421 (43.49)126 (13.02)392 (40.5)Very high EBR (31.40%-40.17%)1.48, 1.38-1.580.9, 0.81-10.73, 0.68-0.77
3032.58%26041460 (31.68)65 (4.48)888 (61.16)
3132.69%7379244 (28.91)50 (5.92)519 (61.49)
3233.09%12300418 (31.19)74 (5.52)812 (60.6)
3333.29%35746748 (36.65)129 (6.32)1121 (54.92)
3433.83%8756410 (33.61)71 (5.82)718 (58.85)
3534.89%23507488 (29.24)81 (4.85)1055 (63.21)
3635.98%164272 (24.83)5 (1.72)207 (71.38)
3740.17%12100523 (27.32)96 (5.02)1269 (66.3)
Table 4 Relationship between endoscopists qualifications and positive/negative lesion detection, n (%)
Endoscopist
EBR
Gastroscopes
GPCs
GPLs
Negative biopsies
Qualification group
OR for GPCs, 95%CI
OR for GPLs, 95%CI
OR for negative biopsies, 95%CI
113.94%146619 (21.84)0 (0)63 (72.41)Low qualification (1466-7379)1.00, -1.00, -1.00, -
3635.98%164272 (24.83)5 (1.72)207 (71.38)
217.06%166829 (23.58)3 (2.44)86 (69.92)
1423.72%3992103 (29.26)15 (4.26)222 (63.07)
2026.35%4666171 (36.85)24 (5.17)255 (54.96)
421.23%5268118 (25.93)22 (4.84)303 (66.59)
2127.49%5890185 (29.55)21 (3.35)398 (63.58)
1223.67%6820189 (28.29)31 (4.64)429 (64.22)
822.30%7349139 (25.23)37 (6.72)357 (64.79)
3132.69%7379244 (28.91)50 (5.92)519 (61.49)
3433.83%8756410 (33.61)71 (5.82)718 (58.85)Moderate qualification (7380-17985)0.92, 0.84-11.13, 0.98-1.311.04, 0.95-1.13
1724.80%9816279 (31.89)51 (5.83)518 (59.2)
1123.48%10006267 (30.34)37 (4.2)551 (62.61)
3740.17%12100523 (27.32)96 (5.02)1269 (66.3)
3233.09%12300418 (31.19)74 (5.52)812 (60.6)
2428.90%12956412 (27.93)86 (5.83)947 (64.2)
1323.68%16172311 (23.52)46 (3.48)924 (69.89)
722.15%16212280 (23.08)66 (5.44)820 (67.6)
2328.37%17985383 (27.81)71 (5.16)887 (64.42)
2932.55%18142421 (43.49)126 (13.02)392 (40.5)High qualification (17986-25385)1.03, 0.94-1.121.20, 1.03-1.390.92, 0.85-1.00
2630.16%18413292 (26.67)50 (4.57)732 (66.85)
1524.18%18608350 (29.79)52 (4.43)737 (62.72)
2529.65%18638426 (30.45)82 (5.86)864 (61.76)
2731.08%19148397 (33.5)64 (5.4)698 (58.9)
621.96%19484238 (24.64)52 (5.38)645 (66.77)
2228.15%22349409 (30.16)61 (4.5)855 (63.05)
3534.89%23507488 (29.24)81 (4.85)1055 (63.21)
2831.39%25385379 (29.61)57 (4.45)829 (64.77)
3032.58%26041460 (31.68)65 (4.48)888 (61.16)Very high qualification (25386-132205)0.98, 0.91-1.071.32, 1.15-1.520.93, 0.86-1.00
1624.42%27558415 (27.36)103 (6.79)957 (63.09)
1925.98%27800423 (29.27)131 (9.07)846 (58.55)
521.53%32126347 (24.47)52 (3.67)968 (68.27)
923.16%35092277 (21.9)64 (5.06)883 (69.8)
3333.29%35746748 (36.65)129 (6.32)1121 (54.92)
1023.44%39896487 (28.15)113 (6.53)1083 (62.6)
318.95%108865527 (29.28)136 (7.56)1052 (58.44)
1824.96%1322051638 (27.42)358 (5.99)3717 (62.23)